Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Armando Anido agrees to leave Auxilium; Adrian Adams new CEO

This article was originally published in Scrip

Executive Summary

Auxilium Pharmaceuticals, a specialty biopharmaceutical company, has appointed Adrian Adams president and CEO. Mr Adams succeeds Armando Anido, who, after discussions with the company's board of directors, has agreed to step down as CEO and president, and has resigned from the board. Mr Adams has over 30 years' experience in the pharmaceutical industry, most recently serving as chair and CEO of Neurologix.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC015561

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel